Professional Documents
Culture Documents
corticotropin superior
Norepinephrine Pronociceptive kappa-opioid
releasing salivatory
release signaling system
hormone nucleus (SSN)
• Headache phase may also be determined by the current
circadian phase of cyclical brainstem activity
• If cyclical brainstem activity is high, the threshold is raised
for transmission of nociceptive trigeminovascular signals,
and nociceptive signals are inhibited.
• If cyclical brainstem activity is low, the threshold is
lowered for the transmission of nociceptive signals, and
thus a migraine headache may occur
Activation of meningeal nociceptors by increased parasympathetic tone. BNST: bed nucleus of stria
terminalis;LH : lateral hypothalamus; PAG : periaqueductal gray; Pir : piriform cortex; PVN : paraventricular
hypothalamic nucleus;SPG : sphenopalatine ganglion; SSN : superior salivatory nucleus; TCC : trigeminal
cervical complex; TG : trigeminalganglion
PHASE 2: AURA
• Initiation and Propagation of Cortical Spreading
Depression (CSD)
– Propagating wave of depolarization in neuronal and glial
cell membranes that is followed by inhibition of cortical
activity, coinciding with the initiation and progression of
aura symptoms
– CSD associated with a wave of hyperemia, followed by a
prolonged phase of cortical oligemia
Cortical Spread Depression
Cortical Spreading Depression (CSD)
Depolarization and
Disruption of
Elevations in repolarization
cell membrane
Influx of Release of
extracellular K of hyperexcitable
ionic gradients
Na and Ca glutamate
neurons
Cortical spreading depression. EEG : electroencephalogram; K: potassium
Aura
PHASE 3: HEADACHE
• The Trigeminovascular Pathway
• Activation of the Trigeminovascular Pathway
• Peripheral Sensitization
• Central Sensitization
Trigeminovascular Pathway
Activation of the Trigeminovascular Pathway
Vasoactive
Arterial
Nociceptive neuropeptides
vasodilatation, mast
Activation of
neurons (ATP, glutamate, K,
hydrogen ions,
cell degranulation meningeal
(duramater) and plasma
CGRP, and nitrous extravasation nociceptors
oxide)
Calcitonin Gene-Related Peptide (CGRP)
1. CGRP is a potent vasodilator, and is present in afferents
innervating meningeal blood vessels
2. CGRP is a neurotransmitter that can enhance synaptic
transmission mediated by glutamatergic signaling
3. Elevations of CGRP can be detected in jugular venous
blood during migraine attacks
4. Intravenous injection of CGRP triggers migraine in
patients with migraine
Calcitonin Gene-Related Peptide (CGRP)
Contraction of smooth
inhibiting CGRP and inhibition of glutamate
muscle cells and
substance P (SP) and CGRP release into
inhibition of endothelial
synthesis the synaptic cleft
NO synthase (eNOS)